Bleichroeder LP - 24 Mar 2025 SCHEDULE 13G/A Report for Evoke Pharma, Inc. Common Shares (EVOK)

Filing Manager
Bleichroeder LP
Reporting Manager
Bleichroeder LP
Security
Evoke Pharma, Inc. Common Shares
Symbol
EVOK
Shares outstanding
1,582,162 shares
Disclosed Ownership
158,058 shares
Ownership
9.99%
Form type
SCHEDULE 13G/A
Filing time
24 Mar 2025, 18:47:51 UTC
Date of event
24 Mar 2025
Previous filing
21 Mar 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Bleichroeder LP 9.99% 158,058 158,058 0 Andrew Gundlach Andrew Gundlach, Chairman and CEO
Bleichroeder Holdings LLC 9.99% 158,058 158,058 0 Andrew Gundlach Andrew Gundlach, Chairman and CEO
Andrew Gundlach 9.99% 158,058 158,058 0 Andrew Gundlach Andrew Gundlach, Individual